BION-1301 is a humanized antibody that blocks A PRoliferation-Inducing Ligand (APRIL) from binding to its receptors, using Aduro’s B-select monoclonal antibody platform. In preclinical studies, BION-1301 eliminated malignant cells and reduced resistance to therapy in models of multiple myeloma.

SparkCures ID 301
Developed By Aduro Biotech, Inc.
Generic Name BION-1301
Treatment Classifications
Treatment Targets
  • APRIL (A Proliferation-Inducing Ligand)

Clinical Trials


There are no resources, links or videos to display for this treatment.